Trade Summary

1 week ago, Mahon Paul A, serving as EVP, GC at United Therapeutics Corp (UTHR), sold 11,000 shares at $513.18 per share, for a total transaction value of $5,644,954.00. Following this transaction, Mahon Paul A now holds 36,781 shares of UTHR.

This sale represents a 23.00% decrease in Mahon Paul A's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, December 24, 2025 and publicly disclosed via SEC Form 4 filing on Monday, December 29, 2025, 5 days after the trade was made.

United Therapeutics Corp operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.